- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.03. | Mirador's massive $400m first round, and other financings | ||
| 22.03. | Idorsia first-in-class hypertension drug gets FDA okay | ||
| 22.03. | Digital diabetes tools 'of little benefit and raise costs' | ||
| 21.03. | Scientists hail first pig-to-man kidney transplant | ||
| 21.03. | MS research network taps Seqster for data sharing | ||
| 21.03. | Eisai backs Leqembi's Japan rollout with insurance policy | ||
| 21.03. | Guth named COO as Bayer revamps top pharma team | ||
| 21.03. | Clasp emerges with $150m for safer T cell engagers | ||
| 20.03. | Orchard's MLD gene therapy becomes costliest US medicine | ||
| 20.03. | Lonza adds biologics capacity with $1.2bn Roche deal | ||
| 20.03. | Iclusig gets FDA nod as frontline therapy for rare leukaemia | ||
| 20.03. | Gates, Wellcome-backed TB vaccine starts phase 3 trial | ||
| 20.03. | EU pharma legislation reforms inch closer to fruition | ||
| 20.03. | Vicore's lung disease digital therapy gets breakthrough tag | ||
| 19.03. | Bayer cues up filings for rival to Astellas' menopause drug | ||
| 19.03. | NIVIDA and J&J partner on 'cutting-edge' AI for surgery | ||
| 19.03. | AZ agrees $2bn deal to buy radiopharma firm Fusion | ||
| 18.03. | Orchard's gene therapy for MLD finally gets US approval | ||
| 18.03. | BMS completes $14bn takeover of Karuna | ||
| 18.03. | NHS will expand use of waiting list-busting AI after pilot | ||
| 18.03. | Havas Lynx takes three Golds at PM Society Awards 2024 | ||
| 18.03. | MS and fibrosis drug developer Contineum files $150m IPO | ||
| 18.03. | Agreement reached on EU health data framework | ||
| 18.03. | OS data set up wider Jemperli use in endometrial cancer | ||
| 18.03. | CAR-Ts set to move earlier in multiple myeloma therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
